{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:47Z","timestamp":1791838187802,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004497","name":"KU Leuven Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C16\/19\/006"],"award-info":[{"award-number":["C16\/19\/006"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.isci.2026.116251","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:29:36Z","timestamp":1780662576000},"page":"116251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["DDERMMAL, a melanocytic long non-coding RNA, confers DNA damage tolerance to melanoma cells"],"prefix":"10.1016","volume":"29","author":[{"given":"Sara","family":"Adnane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvessa","family":"Verheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bonaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2898-748X","authenticated-orcid":false,"given":"Eleonora","family":"Leucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116251_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.isci.2026.116251_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.isci.2026.116251_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.116251_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116251_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116251_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature22794","article-title":"Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance","volume":"546","author":"Shaffer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116251_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2014.11.018","article-title":"Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF\/MEK Cotargeting but Result in Melanoma Drug Addiction","volume":"27","author":"Moriceau","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116251_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward Minimal Residual Disease-Directed Therapy in Melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116251_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116251_bib10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116251_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.02.003","article-title":"Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy","volume":"29","author":"Smith","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116251_bib12","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1158\/0008-5472.CAN-14-1392","article-title":"Inhibition of mTORC1\/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1\u03b1 and Oxidative Phosphorylation in Melanoma","volume":"74","author":"Gopal","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116251_bib13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"Bro\u017cyna","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.isci.2026.116251_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/CMR.0000000000000061","article-title":"Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients","volume":"24","author":"van Lanschot","year":"2014","journal-title":"Melanoma Res."},{"key":"10.1016\/j.isci.2026.116251_bib15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF Regulates Oxidative Metabolism via PGC1\u03b1 and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116251_bib16","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/jid.2015.105","article-title":"MITF Modulates Therapeutic Resistance through EGFR Signaling","volume":"135","author":"Ji","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.isci.2026.116251_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","article-title":"The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma","volume":"4","author":"van Allen","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116251_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","article-title":"Many ways to resistance: How melanoma cells evade targeted therapies","volume":"1871","author":"Kozar","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.isci.2026.116251_bib19","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1158\/0008-5472.CAN-09-0781","article-title":"Intravital Imaging Reveals Transient Changes in Pigment Production and Brn2 Expression during Metastatic Melanoma Dissemination","volume":"69","author":"Pinner","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116251_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41568-019-0154-4","article-title":"Phenotype plasticity as enabler of melanoma progression and therapy resistance","volume":"19","author":"Arozarena","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116251_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature11538","article-title":"Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation","volume":"490","author":"Landsberg","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116251_bib22","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41467-021-21549-x","article-title":"Melanoma subpopulations that rapidly escape MAPK pathway inhibition incur DNA damage and rely on stress signalling","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116251_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A Landscape of Driver Mutations in Melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116251_bib24","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.116251_bib25","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.humpath.2008.03.007","article-title":"Expression of \u03b3-H2AX in melanocytic lesions","volume":"39","author":"Wasco","year":"2008","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.isci.2026.116251_bib26","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jid.2021.01.024","article-title":"Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach","volume":"141","author":"Kim","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.isci.2026.116251_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.jid.5700935","article-title":"Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene Expression","volume":"128","author":"Kaufmann","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.isci.2026.116251_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41419-020-2702-y","article-title":"Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition","volume":"11","author":"Makino","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.116251_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.ade8744","article-title":"Multiple cancers escape from multiple MAPK pathway inhibitors and use DNA replication stress signaling to tolerate aberrant cell cycles","volume":"16","author":"Hoffman","year":"2023","journal-title":"Sci. Signal."},{"key":"10.1016\/j.isci.2026.116251_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41418-024-01377-4","article-title":"The long non-coding RNA ROSALIND protects the mitochondrial translational machinery from oxidative damage","volume":"32","author":"Katopodi","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2026.116251_bib31","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20251507","article-title":"The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity","volume":"223","author":"Cinque","year":"2026","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.116251_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.tcb.2022.01.006","article-title":"LncRNAs in human cancers: signal from noise","volume":"32","author":"Adnane","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.isci.2026.116251_bib33","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/ncb3643","article-title":"Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks","volume":"19","author":"Michelini","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2026.116251_bib34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm.4135","article-title":"p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity","volume":"22","author":"Adriaens","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.116251_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06857","article-title":"Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells","volume":"4","author":"Laurette","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.116251_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010207","article-title":"TFAP2 paralogs facilitate chromatin access for MITF at pigmentation and cell proliferation genes","volume":"18","author":"Kenny","year":"2022","journal-title":"PLoS Genet."},{"key":"10.1016\/j.isci.2026.116251_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2017.11.004","article-title":"Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene","volume":"68","author":"Fontanals-Cirera","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.116251_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.chembiol.2006.04.007","article-title":"RNA-Selective, Live Cell Imaging Probes for Studying Nuclear Structure and Function","volume":"13","author":"Li","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.isci.2026.116251_bib39","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116251_bib40","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/nar\/gkz436","article-title":"Hypoosmotic stress induces R loop formation in nucleoli and ATR\/ATM-dependent silencing of nucleolar transcription","volume":"47","author":"Velichko","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116251_bib41","article-title":"Silencing of GPNMB by siRNA Inhibits the Formation of Melanosomes in Melanocytes in a MITF-Independent Fashion","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116251_bib42","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/s41388-022-02443-2","article-title":"GPNMB: a potent inducer of immunosuppression in cancer","volume":"41","author":"Lazaratos","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.116251_bib43","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1038\/s44319-025-00501-w","article-title":"GPNMB marks a quiescent cell population in melanoma and promotes metastasis formation","volume":"26","author":"Lotti","year":"2025","journal-title":"EMBO Rep."},{"key":"10.1016\/j.isci.2026.116251_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.842496","article-title":"Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship","volume":"12","author":"Slominski","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.116251_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104133","article-title":"BGL3 lncRNA mediates retention of the BRCA1\/BARD1 complex at DNA damage sites","volume":"39","author":"Hu","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2026.116251_bib46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.molcel.2022.01.001","article-title":"SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage","volume":"82","author":"Meza-Sosa","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.116251_bib47","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.molcel.2022.03.034","article-title":"Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS","volume":"82","author":"Wang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.116251_bib48","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1038\/s41467-024-51496-2","article-title":"Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade","volume":"15","author":"Holzgruber","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116251_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1101\/gad.350740.123","article-title":"DNA damage remodels the MITF interactome to increase melanoma genomic instability","volume":"38","author":"Binet","year":"2024","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2026.116251_bib50","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1158\/0008-5472.CAN-09-2913","article-title":"Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas","volume":"70","author":"Giuliano","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116251_bib51","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41556-019-0392-4","article-title":"Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors","volume":"21","author":"Pessina","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2026.116251_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104800","article-title":"Role of condensates in modulating DNA repair pathways and its implication for chemoresistance","volume":"299","author":"Dall\u2019Agnese","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.116251_bib53","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cell.2024.01.015","article-title":"PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA ends","volume":"187","author":"Chappidi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116251_bib54","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1038\/s44319-024-00285-5","article-title":"PARP1 condensates differentially partition DNA repair proteins and enhance DNA ligation","volume":"25","author":"Chin Sang","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.isci.2026.116251_bib61","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature17161","article-title":"Melanoma addiction to the long non-coding RNA SAMMSON","volume":"531","author":"Leucci","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116251_bib55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1261\/rna.079073.121","article-title":"FISH-quant v2: a scalable and modular tool for smFISH image analysis","volume":"28","author":"Imbert","year":"2022","journal-title":"RNA"},{"key":"10.1016\/j.isci.2026.116251_bib56","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"Shevchenko","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2026.116251_bib57","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2026.116251_bib58","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","article-title":"Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ","volume":"13","author":"Cox","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.isci.2026.116251_bib59","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1021\/acs.jproteome.9b00492","article-title":"Evaluating False Transfer Rates from the Match-between-Runs Algorithm with a Two-Proteome Model","volume":"18","author":"Lim","year":"2019","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.isci.2026.116251_bib60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226016263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226016263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:39:24Z","timestamp":1791837564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226016263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2589004226016263"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116251","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DDERMMAL, a melanocytic long non-coding RNA, confers DNA damage tolerance to melanoma cells","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116251"}}